Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Clinical trial NCT00268359 · COMPLETED

Trial details

NCT number: NCT00268359
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2005-05-01
Primary completion: 2006-08-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.